These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1609037)

  • 41. Opioid drugs in maintenance and detoxification treatment of opiate addiction; proposed modification of dispensing restrictions for buprenorphine and buprenorphine combination as used in approved opioid treatment medications. Final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services (HHS)
    Fed Regist; 2012 Dec; 77(235):72752-61. PubMed ID: 23227572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies.
    Mello NK; Mendelson JH; Lukas SE; Gastfriend DR; Teoh SK; Holman BL
    Harv Rev Psychiatry; 1993; 1(3):168-83. PubMed ID: 9384844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human laboratory studies of buprenorphine.
    Mendelson JH; Mello NK
    NIDA Res Monogr; 1992; 121():38-60. PubMed ID: 1406909
    [No Abstract]   [Full Text] [Related]  

  • 44. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.
    Castells X; Kosten TR; Capellà D; Vidal X; Colom J; Casas M
    Am J Drug Alcohol Abuse; 2009; 35(5):339-49. PubMed ID: 20180662
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of opioid antagonists in treating intravenous cocaine abuse.
    Kosten TR; Kleber HD; Morgan C
    Life Sci; 1989; 44(13):887-92. PubMed ID: 2927249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medication development for addictive disorders: the state of the science.
    Vocci FJ; Acri J; Elkashef A
    Am J Psychiatry; 2005 Aug; 162(8):1432-40. PubMed ID: 16055764
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.
    McCance-Katz EF
    Life Sci; 2011 May; 88(21-22):953-8. PubMed ID: 20965297
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
    Newman RG; Gevertz SG
    J Addict Dis; 2011 Oct; 30(4):318-22. PubMed ID: 22026523
    [No Abstract]   [Full Text] [Related]  

  • 50. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
    Jain RB
    NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
    [No Abstract]   [Full Text] [Related]  

  • 51. Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew.
    Roose R; Fuentes L; Cheema M
    Subst Use Misuse; 2012 Aug; 47(10):1117-24. PubMed ID: 22587811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update on the clinical use of buprenorphine: in opioid-related disorders.
    Ducharme S; Fraser R; Gill K
    Can Fam Physician; 2012 Jan; 58(1):37-41. PubMed ID: 22267618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cocaine abuse among methadone maintenance patients: are there effective treatment strategies?
    Rawson RA; McCann MJ; Hasson AJ; Ling W
    J Psychoactive Drugs; 1994; 26(2):129-36. PubMed ID: 7931857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 55. Buprenorphine--background to its development as a treatment for opiate dependence.
    Lewis JW; Walter D
    NIDA Res Monogr; 1992; 121():5-11. PubMed ID: 1406910
    [No Abstract]   [Full Text] [Related]  

  • 56. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
    Feingold A; Oliveto A; Schottenfeld R; Kosten TR
    Am J Addict; 2002; 11(2):111-23. PubMed ID: 12028741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A case series of buprenorphine/naloxone treatment in a primary care practice.
    Doolittle B; Becker W
    Subst Abus; 2011 Oct; 32(4):262-5. PubMed ID: 22014257
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Buprenorphine: beyond methadone?
    Rosen MI; Kosten TR
    Hosp Community Psychiatry; 1991 Apr; 42(4):347-9. PubMed ID: 2050347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comprehensive pharmacologic-psychosocial treatment program for HIV-seropositive cocaine- and opioid-dependent patients. Preliminary findings.
    Avants SK; Margolin A; DePhilippis D; Kosten TR
    J Subst Abuse Treat; 1998; 15(3):261-5. PubMed ID: 9633038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cocaine abuse among methadone-maintained patients.
    Oliveto A; Kosten T; Schottenfeld R; Ziedonis D
    Am J Psychiatry; 1993 Nov; 150(11):1755. PubMed ID: 8214197
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.